Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 0.534 USD 12.4% Market Closed
Market Cap: 14.9m USD
Have any thoughts about
Sol Gel Technologies Ltd?
Write Note

Sol Gel Technologies Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sol Gel Technologies Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Sol Gel Technologies Ltd
NASDAQ:SLGL
Total Current Liabilities
$6.5m
CAGR 3-Years
-12%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Total Current Liabilities
$13B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
1%
I
InterCure Ltd
TASE:INCR
Total Current Liabilities
â‚Ş225.9m
CAGR 3-Years
96%
CAGR 5-Years
69%
CAGR 10-Years
59%
Mediwound Ltd
NASDAQ:MDWD
Total Current Liabilities
$22.6m
CAGR 3-Years
33%
CAGR 5-Years
16%
CAGR 10-Years
22%
S
Seach Medical Group Ltd
TASE:SEMG
Total Current Liabilities
â‚Ş30.1m
CAGR 3-Years
60%
CAGR 5-Years
60%
CAGR 10-Years
21%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Total Current Liabilities
â‚Ş151m
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
2%
No Stocks Found

Sol Gel Technologies Ltd
Glance View

Market Cap
14.9m USD
Industry
Pharmaceuticals

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

SLGL Intrinsic Value
0.721 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Sol Gel Technologies Ltd's Total Current Liabilities?
Total Current Liabilities
6.5m USD

Based on the financial report for Sep 30, 2024, Sol Gel Technologies Ltd's Total Current Liabilities amounts to 6.5m USD.

What is Sol Gel Technologies Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
-4%

Over the last year, the Total Current Liabilities growth was 45%. The average annual Total Current Liabilities growth rates for Sol Gel Technologies Ltd have been -12% over the past three years , -4% over the past five years .

Back to Top